Dan Lu
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 31
- HER2/EGFR in Cancer Research 23
- CAR-T cell therapy research 6
- Cancer Treatment and Pharmacology 4
-
- Monoclonal and Polyclonal Antibodies Research 21
- Co-authors
- Zhenping Zhu (9 shared papers)Peter Böhlen (7 shared papers)Sandhya Girish (17 shared papers)Larry Witte (7 shared papers)Xenia Jimenez (6 shared papers)Amita Joshi (5 shared papers)Haifan Zhang (5 shared papers)Joo‐Hee Yi (4 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (7 papers)Blood (3 papers)Cancer Research (3 papers)Clinical Pharmacokinetics (3 papers)Journal of Immunological Methods (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Dan Lu
62 papers receiving 1.9k citations
Dan Lu's Hit Papers
Peers
Comparison fields: 5 of 119
- Radiology, Nuclear Medicine and Imaging 777
- Oncology 810
- Molecular Biology 802
- Immunology 213
- Genetics 94
Countries citing papers authored by Dan Lu
This map shows the geographic impact of Dan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Lu more than expected).
Fields of papers citing papers by Dan Lu
This network shows the impact of papers produced by Dan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Lu. The network helps show where Dan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 208 | |
| 2 | 2005 | 160 | |
| 3 | 2012 | 130 | |
| 4 | 2004 | 109 | |
| 5 | Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library. | 1998 | 96 |
| 6 | 2014 | 68 | |
| 7 | 2004 | 55 | |
| 8 | Understanding the impact of cultivated land-use changes on China's grain production potential and policy implications: A perspective of non-agriculturalization, non-grainization, and marginalization Hit paper breakdown → | 2024 | 54 |
| 9 | 2021 | 52 | |
| 10 | 2014 | 52 | |
| 11 | 2018 | 51 | |
| 12 | 2019 | 49 | |
| 13 | 2021 | 47 | |
| 14 | 2021 | 47 | |
| 15 | 1999 | 45 | |
| 16 | 2011 | 45 | |
| 17 | Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor. | 2001 | 45 |
| 18 | 2016 | 44 | |
| 19 | 2014 | 37 | |
| 20 | 2003 | 36 |
About Dan Lu
Dan Lu is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Global and Planetary Change and Pathology and Forensic Medicine, having authored 63 papers that have together received 2.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (23 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Glycosylation and Glycoproteins Research (7 papers), Land Use and Ecosystem Services (6 papers), CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (777 citations), Oncology (810 citations), Molecular Biology (802 citations), Immunology (213 citations) and Genetics (94 citations). Dan Lu has collaborated with scholars based in United States, China and France. Frequent co-authors include Zhenping Zhu, Peter Böhlen, Sandhya Girish, Larry Witte, Xenia Jimenez, Amita Joshi, Haifan Zhang, Joo‐Hee Yi, Manish Gupta and Daniel J. Hicklin. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Blood, Cancer Research, Clinical Pharmacokinetics and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.